Ethacrynic acid and the sulfa-sensitive patient

Archives of Internal Medicine

Volumn 163, Issue 1, 2003, Pages 116-117

  Wall, Geoffrey C ^a   Bigner, Dori ^a   Craig, Steven ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; BUMETANIDE; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETACRYNIC ACID; FUROSEMIDE; GLIBENCLAMIDE; GRISEOFULVIN; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT; TORASEMIDE;

AGED; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIURESIS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG UTILIZATION; DYSPNEA; HEART ATRIUM FIBRILLATION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOPOROSIS; OTOTOXICITY; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROVOCATION TEST; RASH; SLEEP APNEA SYNDROME; STEVENS JOHNSON SYNDROME; SYMPTOM;

EID: 0037434059     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.1.116     Document Type: Article

References (15)

1. Brater DC. Diuretic therapy. N Engl J Med. 1998; 339:387-395.
2. Hebel SK, ed. Drug Facts and Comparisons 2002. St Louis, Mo: Facts & Comparisons Inc; 2002.
3. Brater DC. Pharmacology of diuretics. Am J Med Sci. 2000;319:38-50.
4. Rybak LP. Ototoxicity of ethacrynic acid (a persistent clinical problem). J Laryngol Otol. 1988; 102:518-520.
5. American Society of Health-System Pharmacists. Drug Product Shortages Management Resource Center: Diuretics. Available at: http://www.ashp.org/shortage/diuretics.html. Accessed January 30, 2002.
6. Boxer MB, Dykewicz MS, Patterson R, Greenberger PA, Kelly JF. The management patients with sulfonamide allergy. N Engl Reg Allergy Proc. 1988;9:219-223.
7. Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Pergamon Press; 1990:721-725.
8. Blose JS, Adams KF, Patterson JH. Torsemide: a pyridine-sulfonylurea loop diuretic. Ann Pharmacother. 1995;29:396-402.
9. Naisbitt DJ, Hough SJ, Gill HJ, Pirmohamed M, Kitteringham NR, Park BK Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br J Pharmacol. 1999;126:1393-1407.
10. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism o[sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med. 1986;105:179-184.
11. Knowles S, Shapiro L, Shear NH. Should Celecoxib be contraindicated in patients who are allergic to sulfonamides? revisiting the meaning of "sulfa" allergy. Drug Saf. 2001;24:239-247.
12. Harle D, Baldo B, Wells J. Drugs as allergens: detection and combing site specificities of IgE antibodies to sulfamethoxazole. Mol Immunol. 1988;25:1347-1354.
13. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-1607.
14. Bianchine JR, Alexander MS, Andresen BD, Ng KJ. The aspirin/Reye's syndrome link. Lancet. 1982;2:1333.
15. Wolkenstein P, Revuz J. Drug-induced severe skin reactions: incidence, management, and prevention. Drug Saf. 1995;13:56-68.